Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Endocrine, Metabolic and Immune Disorders - Drug Targets

eISSN: 2212-3873pISSN: 1871-5303

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
3.8
Impact Factor
< 5
SNIP
0.7

Journal Specifications

Overview
  • Publisher
    BENTHAM SCIENCE PUBL LTD
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less

Recently Published Papers

Year-wise Publication

FAQs

Since when has Endocrine, Metabolic and Immune Disorders - Drug Targets been publishing? Faqs

The Endocrine, Metabolic and Immune Disorders - Drug Targets has been publishing since 2001 till date.

How frequently is the Endocrine, Metabolic and Immune Disorders - Drug Targets published? Faqs

Endocrine, Metabolic and Immune Disorders - Drug Targets is published Bi-monthly.

Who is the publisher of Endocrine, Metabolic and Immune Disorders - Drug Targets? Faqs

The publisher of Endocrine, Metabolic and Immune Disorders - Drug Targets is BENTHAM SCIENCE PUBL LTD.

How can I view the journal metrics of Endocrine, Metabolic and Immune Disorders - Drug Targets on editage? Faqs

For the Endocrine, Metabolic and Immune Disorders - Drug Targets metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Endocrine, Metabolic and Immune Disorders - Drug Targets? Faqs

The eISSN number is 2212-3873 and pISSN number is 1871-5303 for Endocrine, Metabolic and Immune Disorders - Drug Targets.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.